Guided Therapeutics (GTHP) Stock Chart & Stock Price History $0.13 -0.04 (-25.29%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Chart Stock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Guided Therapeutics Stock Price Performance 5 Day Performance-20.63%1 Month Performance-31.35%3 Month Performance-20.63%6 Month Performance+25.74%Year-To-Date Performance-17.26%1 Year Performance-25.29% Receive GTHP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address This is the worst sign for the U.S. stock market in 50 years (Ad)The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone" Click here to see Dan's new, urgent warning about the U.S. market for 2025. GTHP Stock Chart for Sunday, December, 22, 2024 GTHP Chart by TradingView Guided Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$0.17$0.13-25.29%$0.13$0.135,003 shs$7.75 million12/19/2024$0.16$0.17+4.94%$0.17$0.1548,890 shs$10.37 million12/18/2024$0.16$0.16+1.25%$0.16$0.16606 shs$9.88 million12/17/2024$0.17$0.16-7.94%$0.18$0.1657,655 shs$9.76 million12/16/2024$0.17$0.17$0.18$0.1723,422 shs$10.60 million12/13/2024$0.17$0.17+0.75%$0.17$0.171,051 shs$10.60 million Get the Latest News and Ratings for GTHP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$0.18$0.17-1.43%$0.17$0.177,000 shs$10.53 million12/11/2024$0.17$0.18+0.69%$0.18$0.1712,362 shs$10.68 million12/10/2024$0.17$0.17+1.64%$0.18$0.172,429 shs$10.60 million12/09/2024$0.17$0.17$0.17$0.172,900 shs$10.43 million12/06/2024$0.17$0.17-1.16%$0.17$0.1710,022 shs$10.43 million12/05/2024$0.18$0.17-1.14%$0.17$0.171,972 shs$10.56 million12/04/2024$0.18$0.18$0.18$0.171,765 shs$10.68 million12/03/2024$0.16$0.18+9.37%$0.18$0.1625,468 shs$10.68 million12/02/2024$0.19$0.16-15.79%$0.16$0.16100 shs$9.76 million11/29/2024$0.16$0.19+18.75%$0.19$0.19100 shs$11.59 million11/28/2024$0.16$0.16$0.20$0.164,369 shs$9.76 million11/27/2024$0.19$0.16-15.79%$0.20$0.161,969 shs$9.76 million11/26/2024$0.16$0.19+18.75%$0.20$0.163,000 shs$11.59 million11/25/2024$0.19$0.16-13.51%$0.19$0.1612,123 shs$9.76 million11/22/2024$0.18$0.19+3.47%$0.19$0.165,400 shs$11.29 million11/21/2024$0.20$0.18-8.31%$0.18$0.18100 shs$10.91 million Related Companies CollPlant Biotechnologies Stock Chart Daxor Stock Chart Spectral AI Stock Chart Envoy Medical Stock Chart SurgePays Stock Chart NEXGEL Stock Chart Vivos Stock Chart Beyond Air Stock Chart Neuronetics Stock Chart Precision Optics Stock Chart Receive GTHP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:GTHP) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guided Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GTHP Stock Alerts